Publication: 3712

Publication: 3712

The effect of intrinsic subtype on inhibition of tumor growth by anastrozole vs. fulvestrant vs. the combination: Results from the Alliance neoadjuvant endocrine therapy (NET) ALTERNATE trial.

URL

Google Scholar

Citation:: Cancer Res vol 82 (12_suppl) Abstract CT026

Meeting Instance:: AACR 2022
Year:: 2022
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3910

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: AstraZeneca, Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Matthew J. Ellis Meenakshi Anurag Jeremy Hoog Aranzazu Fernandez-Martinez Cheng Fan Richard Gibbs Souzan Sanati Kiran Vij Travis Dockter Olwen Hahn Joseph Guenther Abigail Caudle Erika Crouch Amy Tiersten Monica Mita Wajeeha Razaq Tina J. Hieken Yang Wang A. Marilyn Leitch Gary W. Unzeitig Eric Winer Anna Weiss Kelly Hunt Ann H. Partridge Charles M. Perou Cynthia X. Ma Vera Suman Lisa A Carey

Networks:: CA016, KY015, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OK003, LAPS-TX011, LAPS-TX035, NEWMEXICO, NY021, NY167, TX041, TX190

Study: Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: